SitesBLAST
Comparing AO353_18585 FitnessBrowser__pseudo3_N2E3:AO353_18585 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
2v27B Structure of the cold active phenylalanine hydroxylase from colwellia psychrerythraea 34h (see paper)
58% identity, 98% coverage: 4:262/263 of query aligns to 2:264/272 of 2v27B
4etlA Crystallographic structure of phenylalanine hydroxylase from chromobacterium violaceum f258a mutation (see paper)
50% identity, 86% coverage: 14:238/263 of query aligns to 25:251/277 of 4etlA
1ltvA Crystal structure of chromobacterium violaceum phenylalanine hydroxylase, structure with bound oxidized fe(iii) (see paper)
49% identity, 88% coverage: 14:245/263 of query aligns to 23:256/275 of 1ltvA
3tcyA Crystallographic structure of phenylalanine hydroxylase from chromobacterium violaceum (cpah) bound to phenylalanine in a site distal to the active site (see paper)
49% identity, 88% coverage: 14:245/263 of query aligns to 25:258/277 of 3tcyA
- active site: H132 (= H121), H137 (= H126), E178 (= E166), S197 (= S185)
- binding cobalt (ii) ion: H132 (= H121), H137 (= H126), E178 (= E166)
- binding phenylalanine: A152 (≠ T141), Y153 (= Y142), K159 (≠ Q148), L169 (= L157), T248 (≠ A235), P250 (≠ E237), D251 (= D238), F252 (≠ I239)
1ltzA Crystal structure of chromobacterium violaceum phenylalanine hydroxylase, structure has bound iron (iii) and oxidized cofactor 7, 8-dihydrobiopterin (see paper)
51% identity, 82% coverage: 18:233/263 of query aligns to 29:246/274 of 1ltzA
P04177 Tyrosine 3-monooxygenase; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Rattus norvegicus (Rat) (see 7 papers)
39% identity, 79% coverage: 17:224/263 of query aligns to 223:434/498 of P04177
- Q310 (≠ P100) mutation to H: Does not affect Vmax for phenylalanine. Increases KM for phenylalanine.
- H323 (≠ Y113) mutation to Y: Does not affect Vmax for phenylalaninet. Increases KM for phenylalanine.
- H331 (= H121) binding
- H336 (= H126) binding
- W372 (= W162) mutation to F: Does not affect substrate specificity.
- E376 (= E166) binding
- D425 (≠ I215) Important for substrate specificity; mutation to V: Shifts substrate specificity from tyrosine to phenylalanine.
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 19 modified: Phosphoserine; by CaMK2
- 31 modified: Phosphoserine
- 40 modified: Phosphoserine; by CaMK2 and PKA
P17289 Tyrosine 3-monooxygenase; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Bos taurus (Bovine) (see 2 papers)
38% identity, 79% coverage: 17:224/263 of query aligns to 216:427/491 of P17289
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 19 modified: Phosphoserine; by CaMK2
- 31 modified: Phosphoserine
- 40 modified: Phosphoserine; by CaMK2 and PKA
2tohA Tyrosine hydroxylase catalytic and tetramerization domains from rat (see paper)
38% identity, 79% coverage: 17:224/263 of query aligns to 61:272/336 of 2tohA
- active site: H169 (= H121), H174 (= H126), E214 (= E166), S233 (= S185)
- binding fe (iii) ion: H169 (= H121), H174 (= H126), E214 (= E166)
- binding 7,8-dihydrobiopterin: V129 (= V81), L132 (= L84), L133 (≠ I85), Y138 (≠ F90), P165 (= P117), E170 (= E122), Y209 (= Y161)
2xsnA Crystal structure of human tyrosine hydroxylase catalytic domain
38% identity, 79% coverage: 17:224/263 of query aligns to 61:272/335 of 2xsnA
6zvpD Atomic model of the em-based structure of the full-length tyrosine hydroxylase in complex with dopamine (residues 40-497) in which the regulatory domain (residues 40-165) has been included only with the backbone atoms (see paper)
38% identity, 79% coverage: 17:224/263 of query aligns to 183:394/458 of 6zvpD
Sites not aligning to the query:
6zn2A Partial structure of tyrosine hydroxylase in complex with dopamine showing the catalytic domain and an alpha-helix from the regulatory domain involved in dopamine binding. (see paper)
38% identity, 79% coverage: 17:224/263 of query aligns to 60:271/335 of 6zn2A
P07101 Tyrosine 3-monooxygenase; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Homo sapiens (Human) (see 32 papers)
38% identity, 79% coverage: 17:224/263 of query aligns to 253:464/528 of P07101
- E259 (= E23) to G: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- T276 (≠ G40) to P: in ARSEGS; parkinsonian symptoms in infancy; no effect on tyrosine 3-monooxygenase activity; dbSNP:rs28934581
- P301 (= P61) to A: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity
- F309 (≠ V69) to S: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- T314 (= T74) to M: in ARSEGS; parkinsonian symptoms in infancy; loss of about 80% of tyrosine 3-monooxygenase activity; dbSNP:rs121917764
- R319 (≠ A79) to P: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- R328 (≠ Q88) to W: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity; dbSNP:rs1428589694
- R337 (≠ K97) to H: in ARSEGS; parkinsonian symptoms in infancy; no effect on tyrosine 3-monooxygenase activity; dbSNP:rs28934580
- C359 (≠ I119) to F: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs121917765
- F375 (= F135) to L: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; shifted substrate specificity from tyrosine to phenylalanine and Dopa; dbSNP:rs763198914
- A376 (= A136) to V: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity
- L387 (= L147) to M: in ARSEGS; no effect on tyrosine 3-monooxygenase activity
- I394 (≠ R154) to T: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- T399 (≠ R159) to M: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs1057520384
- Q412 (≠ T172) to K: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; reduced affinity for L-tyrosine; dbSNP:rs121917762
- G414 (≠ Q174) to R: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs370962049
- G428 (≠ K188) to R: in ARSEGS; phenotype with prominent levodopa-responsive myoconus-dystonia (M-D); dbSNP:rs1264884607
- R441 (≠ Q201) to P: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity; dbSNP:rs367874223
Sites not aligning to the query:
- 19 modified: Phosphoserine; by CaMK2; S → C: found in a patient with ARSEGS; unknown pathological significance; dbSNP:rs766704202
- 62 modified: Phosphoserine; S→A: Affects subcellular localization. Accumulates mainly in the soma of the neuroblastoma cells.; S→E: Does not affect subcellular localization. Distributed throughout the soma and neurites.
- 71 modified: Phosphoserine; by CaMK2 and PKA; S→E: Suppresses feedback inhibition induced by dopamine. Suppresses feedback inhibition induced by dopamine; when associated with A-207.
- 112 V → M: in dbSNP:rs6356
- 207 C → Y: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; C→A: Suppresses the decrease in tyrosine 3-monooxygenase activity induced by NEM modification. Suppresses feedback inhibition induced by dopamine; when associated with E-71.
- 227 D → G: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- 233 R → H: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; shifted substrate specificity from tyrosine to phenylalanine and Dopa; dbSNP:rs80338892
- 236 L → P: in ARSEGS; severe parkinsonian symptoms in early infancy; strongly reduced stability and tyrosine 3-monooxygenase activity; rare mutation; dbSNP:rs121917763
- 241 A → T: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs1260455415
- 246 H → Y: in ARSEGS; loss of about 40% of tyrosine 3-monooxygenase activity
- 247 G → S: in ARSEGS; loss of about 50% of tyrosine 3-monooxygenase activity; shifted substrate specificity from tyrosine to phenylalanine and Dopa; dbSNP:rs762304556
- 467 S → G: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity
- 492 P → L: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity; dbSNP:rs767635052
- 494 T → M: in ARSEGS; parkinsonian symptoms in infancy; no effect on tyrosine 3-monooxygenase activity; dbSNP:rs45471299
- 498 D → G: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs771351747
- 499 V → M: in dbSNP:rs1800033
- 510 L → Q: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
P90986 Tyrosine 3-monooxygenase; Abnormal catecholamine distribution protein 2; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Caenorhabditis elegans (see 4 papers)
33% identity, 83% coverage: 12:228/263 of query aligns to 234:454/519 of P90986
Sites not aligning to the query:
- 35 modified: Phosphoserine; by PKA
- 276:519 mutation Missing: In e1112; spontaneously induces activation of the crh-1/CREB1 transcription factor in cholinergic SIA neurons in the absence and presence of food. Reduces swimming-induced paralysis in response to amphetamine. Defective male mating behavior.
5jk8A Phenylalanine hydroxylase from dictyostelium - bh2, norleucine complex
35% identity, 81% coverage: 17:230/263 of query aligns to 142:359/390 of 5jk8A
- active site: H250 (= H121), H255 (= H126), E295 (= E166), S314 (= S185)
- binding fe (iii) ion: H250 (= H121), H255 (= H126), E295 (= E166)
- binding 7,8-dihydrobiopterin: L214 (≠ I85), A216 (≠ F87), F219 (= F90), S287 (≠ A158), Y290 (= Y161)
- binding norleucine: Y242 (= Y113), T243 (≠ L114), H250 (= H121), S314 (= S185), S315 (= S186)
- binding piperazine-n,n'-bis(2-ethanesulfonic acid): T203 (= T74), R226 (≠ K97), D266 (≠ E137)
Sites not aligning to the query:
5jk5A Phenylalanine hydroxylase from dictyostelium - bh2 complex
35% identity, 81% coverage: 17:230/263 of query aligns to 151:368/400 of 5jk5A
- active site: H259 (= H121), H264 (= H126), E304 (= E166), S323 (= S185)
- binding fe (iii) ion: H259 (= H121), H264 (= H126), E304 (= E166)
- binding 7,8-dihydrobiopterin: G221 (≠ A83), L222 (= L84), L223 (≠ I85), F228 (= F90), L229 (≠ F91), S296 (≠ A158), Y299 (= Y161)
- binding piperazine-n,n'-bis(2-ethanesulfonic acid): T212 (= T74), P271 (= P133), D275 (≠ E137)
Sites not aligning to the query:
P70080 Tryptophan 5-hydroxylase 1; Tryptophan 5-monooxygenase 1; EC 1.14.16.4 from Gallus gallus (Chicken) (see paper)
36% identity, 79% coverage: 17:224/263 of query aligns to 165:376/445 of P70080
- Y236 (≠ L84) binding
- R258 (= R106) binding
- T266 (≠ L114) binding
- H273 (= H121) binding
- H278 (= H126) binding
- E318 (= E166) binding
- S337 (= S185) binding
- I367 (= I215) binding
3e2tA The catalytic domain of chicken tryptophan hydroxylase 1 with bound tryptophan (see paper)
36% identity, 79% coverage: 17:224/263 of query aligns to 61:272/307 of 3e2tA
- active site: H169 (= H121), H174 (= H126), E214 (= E166), S233 (= S185)
- binding fe (iii) ion: H169 (= H121), H174 (= H126), E214 (= E166)
- binding imidazole: H169 (= H121), H174 (= H126), E214 (= E166)
- binding tryptophan: R154 (= R106), Y161 (= Y113), T162 (≠ L114), E164 (= E116), P165 (= P117), H169 (= H121), F215 (= F167), S233 (= S185), I263 (= I215)
7zifA Crystal structure of human tryptophan hydroxylase 1 in complex with inhibitor km-480 (see paper)
34% identity, 79% coverage: 17:224/263 of query aligns to 61:272/291 of 7zifA
- binding fe (iii) ion: H169 (= H121), H174 (= H126), E214 (= E166)
- binding (2R)-2-azanyl-5-[[2-[3-methyl-2,6-bis(oxidanylidene)-7-(phenylmethyl)purin-8-yl]sulfanyl-3H-benzimidazol-5-yl]amino]-5-oxidanylidene-pentanoic acid: Y132 (≠ L84), L133 (≠ I85), P135 (≠ F87), F138 (= F90), Y161 (= Y113), T162 (≠ L114), P165 (= P117), H169 (= H121), E214 (= E166)
1mlwA Crystal structure of human tryptophan hydroxylase with bound 7,8-dihydro-l-biopterin cofactor and fe(iii) (see paper)
34% identity, 79% coverage: 17:224/263 of query aligns to 61:272/290 of 1mlwA